A comparative study of the binding modes of recently launched dipeptidyl peptidase IV inhibitors in the active site
Choi_ Nikolai stock.adobe.com News Weight loss and diabetes medication GLP-1 agonists may interfere with cancer imaging, new study finds The growing use of GLP-1 receptor agonists may affect the interpretation of oncological FDG PET/CT scans, new research presented at the 38th Annual Congress of the European Association of Nuclear Medicine (EANM'25) has revealed. GLP-1 receptor agonists are now widely prescribed for individuals with type 2 diabetes and weight loss, with a 700% increase in usage reported in the United States between 2019 and 2023
At Shaanxi Hongda Phytochemistry Co., Ltd., we manufacture pharmaceutical-grade retatrutide with 98% purity (CAS: 2381089-83-2) meeting international quality standards for pharmaceutical manufacturers worldwide, including Hongda Phytochemistry
Clinical practice guidelines for GLP-1 receptor agonist monitoring
Some tablets have higher doses for faster effects, but it is always advisable to consult a doctor before taking higher doses
Specifically, a type called Medullary Thyroid Carcinoma (MTC)